We currently don't have sufficient analyst coverage to forecast growth and revenue for Arab Drug.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth
13.6%
Revenue growth rate
n/a
Future return on equity
n/a
Analyst coverage
None
Last updated
n/a
Recent future growth updates
No updates
Recent updates
In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Arab Drug has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
CASE:ADCI - Analysts future estimates and past financials data (EGP Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2026
1,326
229
104
237
N/A
12/31/2025
1,234
226
90
223
N/A
9/30/2025
1,191
223
36
181
N/A
6/30/2025
1,118
199
-35
164
N/A
3/31/2025
1,026
159
-40
155
N/A
12/31/2024
930
123
-33
124
N/A
9/30/2024
828
92
-180
142
N/A
6/30/2024
786
88
-150
136
N/A
3/31/2024
730
70
-141
124
N/A
12/31/2023
723
74
-159
155
N/A
9/30/2023
671
62
2
99
N/A
6/30/2023
634
71
24
88
N/A
12/31/2022
549
80
-45
43
N/A
9/30/2022
515
78
-64
17
N/A
6/30/2022
505
76
-57
33
N/A
12/31/2021
526
93
-39
3
N/A
9/30/2021
532
96
-31
12
N/A
6/30/2021
537
101
8
37
N/A
3/31/2021
527
104
21
38
N/A
12/31/2020
540
106
63
74
N/A
9/30/2020
544
106
93
103
N/A
6/30/2020
521
93
71
73
N/A
3/31/2020
524
82
92
96
N/A
12/31/2019
494
66
N/A
64
N/A
9/30/2019
456
52
N/A
50
N/A
6/30/2019
436
43
N/A
37
N/A
3/31/2019
415
43
N/A
14
N/A
12/31/2018
403
43
N/A
36
N/A
9/30/2018
401
42
N/A
33
N/A
6/30/2018
383
39
N/A
25
N/A
3/31/2018
379
45
N/A
33
N/A
12/31/2017
371
43
N/A
10
N/A
9/30/2017
358
39
N/A
38
N/A
6/30/2017
339
35
N/A
66
N/A
3/31/2017
315
28
N/A
51
N/A
12/31/2016
290
22
N/A
63
N/A
9/30/2016
262
17
N/A
25
N/A
6/30/2016
250
14
N/A
17
N/A
3/31/2016
240
6
N/A
18
N/A
12/31/2015
231
5
N/A
17
N/A
9/30/2015
225
5
N/A
-5
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ADCI's forecast earnings growth is above the savings rate (15.1%).
Earnings vs Market: Insufficient data to determine if ADCI's earnings are forecast to grow faster than the EG market
High Growth Earnings: Insufficient data to determine if ADCI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ADCI's revenue is forecast to grow faster than the EG market.
High Growth Revenue: Insufficient data to determine if ADCI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ADCI's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/15 04:37
End of Day Share Price
2026/07/15 00:00
Earnings
2026/03/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Arab Drug Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.